Skip to content

Prospective intervention study of radiation therapy omission after partial mastectomy in invasive breast cancer

Prospective intervention study of radiation therapy omission after partial mastectomy in invasive breast cancer - Prospective intervention study of radiation therapy omission after partial mastectomy in invasive breast cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000040249
Enrollment
450
Registered
2020-05-01
Start date
2020-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Omission of radiation therapy after breast-conserving surgery

Sponsors

Department of Breast Surgical Oncology, Breast Oncology Center, Cancer Institute Hospital of Japanese Foundation for Cancer Research
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1) Histologically diagnosed invasive breast cancer (irrespective of histological type). 2) TNM classification: pT1-T2pN0 3) Partial mastectomy is performed by vertical resection in which lateral stump can be diagnosed. 4) There is no residual cancer on the skin or pectoralis major muscle. 5) Partial mastectomy specimens are pathologically examined at intervals of 5 mm, and an experienced breast pathologist has concluded complete resection (the distance from the lateral stump to the cancer cells is longer than 5 mm). 6) Histologically no lymph-vascular invasion detected. 7) Age at registration is 20 years or older 8) Performance status (ECOG) is 0 or 1. 9) Main organ functions are maintained. 10) Patients have given their consent to participate in the study through the documents.

Exclusion criteria

Exclusion criteria: 1) Cases of additional resection during surgery(However, registration is possible if the specimen before additional resection can be diagnosed as complete resection) 2) Cases of excisional biopsy 3) Patients who have not undergone standard surgery on lymph nodes 4) BRCA mutation positive cases 5)When the doctor in charge determines that it is inappropriate

Design outcomes

Primary

MeasureTime frame
Incidence of invasive cancer in the preserved breast (limited to the first recurrence)

Secondary

MeasureTime frame
1. Incidence of cancer in the preserved breast 2. Incidence of true recurrence (TR) and new primary lesion (NP) 3. Recurrence-free survival rate 4. Overall survival rate 5. Search for risk factors for ipsilateral breast cancer (Age, ER status, PgR status, HER2 status, tumor diameter, Nuclear grade) 6. Incidence of contralateral breast cancer 7. Incidence of distant metastases 8. Incidence of local recurrence rate 9. Incidence of symptomatic pneumonitis 10. Incidence rate of symptomatic cardiac dysfunction 11. Incidence and degree of skin disorders

Countries

Japan

Contacts

Public ContactTakayuki Ueno

Cancer Institute Hospital of Japanese Foundation for Cancer Research Department of Breast Surgical Oncology, Breast Oncology Center

takayuki.ueno@jfcr.or.jp0335200111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026